A Prospective Study on Incidence of Febrile Neutropenia and Impact of Prophylactic G-CSF Use in Patients Receiving Moderate to High Intensity Chemotherapy

Febrile neutropenia (FN) remains a complication of myelosuppressive chemotherapy during granulocyte colony-stimulating factor (G-CSF) prophylaxis. This six-month, single-centre prospective observational study enrolled 130 adults consecutively at KIMS Hospital, Secunderabad, to describe FN and hospitalization during moderate-or high-intensity chemotherapy with prophylactic G-CSF. The study recorded FN using a temperature threshold of 38.3°C and concurrent absolute neutrophil count below 500 cells/mm³. Sixty-four patients received moderate-intensity chemotherapy and 66 received high-intensity chemotherapy. Seven patients developed FN (5.38%), and 20 were hospitalized during treatment (15.38%). The study summary identified seven hospitalized patients who met the FN criteria. FN and hospitalization represent distinct outcomes in this cohort. The 5.38% figure describes observed FN during prophylaxis. Estimating the effect of G-CSF would require a comparable group without prophylaxis. The findings provide a centre-specific estimate for this treated cohort.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24374650
Primary Topic
Neutropenia and Cancer Infections
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Prospective Study on Incidence of Febrile Neutropenia and Impact of Prophylactic G-CSF Use in Patients Receiving Moderate to High Intensity Chemotherapy

Dr. Sabahat Sakina, Deeti Lakshmi Prasanna, Dolla Raj Kumar, G. Surya Prakash Reddy1 et al.
Zenodo (CERN European Organization for Nuclear Research)
Neutropenia and Cancer Infections
article

A Prospective Study on Incidence of Febrile Neutropenia and Impact of Prophylactic G-CSF Use in Patients Receiving Moderate to High Intensity Chemotherapy

Dr. Sabahat Sakina, Deeti Lakshmi Prasanna, Dolla Raj Kumar, G. Surya Prakash Reddy1, Elarpu Preethi
article en

Abstract

Febrile neutropenia (FN) remains a complication of myelosuppressive chemotherapy during granulocyte colony-stimulating factor (G-CSF) prophylaxis. This six-month, single-centre prospective observational study enrolled 130 adults consecutively at KIMS Hospital, Secunderabad, to describe FN and hospitalization during moderate-or high-intensity chemotherapy with prophylactic G-CSF. The study recorded FN using a temperature threshold of 38.3°C and concurrent absolute neutrophil count below 500 cells/mm³. Sixty-four patients received moderate-intensity chemotherapy and 66 received high-intensity chemotherapy. Seven patients developed FN (5.38%), and 20 were hospitalized during treatment (15.38%). The study summary identified seven hospitalized patients who met the FN criteria. FN and hospitalization represent distinct outcomes in this cohort. The 5.38% figure describes observed FN during prophylaxis. Estimating the effect of G-CSF would require a comparable group without prophylaxis. The findings provide a centre-specific estimate for this treated cohort.

Zenodo (CERN European Organization for Nuclear Research)
Neutropenia and Cancer Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon